 | • レポートコード：D005-03427 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、がんヤヌスキナーゼ阻害剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。がんヤヌスキナーゼ阻害剤の種類別市場規模（モメロチニブ、レスタウルチニブ、パクリチニブ）、用途別市場規模（肺がん、卵巣がん、乳がん、膵臓がん、肝細胞がん、結腸直腸がん、頭頸部扁平上皮がん、前立腺がん、膠芽腫）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Laboratories、Hanmi Pharmaceuticals、Celon Pharmaceuticals、Asana Biosciences、Gilead Sciences、Astra Zeneca、Kyowa Hakko、Eli Lilly、Dynamic Pharma、Incyte、Moleculin、Pfizer ・地域別グローバル市場分析 2015年-2020年 ・がんヤヌスキナーゼ阻害剤の北米市場（アメリカ、カナダ、メキシコ） ・がんヤヌスキナーゼ阻害剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・がんヤヌスキナーゼ阻害剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・がんヤヌスキナーゼ阻害剤の南米市場（ブラジル、アルゼンチン） ・がんヤヌスキナーゼ阻害剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：モメロチニブ、レスタウルチニブ、パクリチニブ ・用途別分析：肺がん、卵巣がん、乳がん、膵臓がん、肝細胞がん、結腸直腸がん、頭頸部扁平上皮がん、前立腺がん、膠芽腫 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Cancer Janus Kinase Inhibitor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Cancer Janus Kinase Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cancer Janus Kinase Inhibitor market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cancer Janus Kinase Inhibitor market has been segmented into
Momelotinib
Lestaurtinib
Pacritinib
By Application, Cancer Janus Kinase Inhibitor has been segmented into:
Lung Cancer
Ovarian Cancer
Breast Cancer
Pancreatic Cancer
Hepatocellular Carcinoma
Colorectal cancer
Head & Neck Squamous Cell Carcinoma
Prostate Cancer
Glioblastoma
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cancer Janus Kinase Inhibitor market presented in the report. This section sheds light on the sales growth of different regional and country-level Cancer Janus Kinase Inhibitor markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cancer Janus Kinase Inhibitor market.
The report offers in-depth assessment of the growth and other aspects of the Cancer Janus Kinase Inhibitor market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Cancer Janus Kinase Inhibitor Market Share Analysis
Cancer Janus Kinase Inhibitor competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cancer Janus Kinase Inhibitor sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cancer Janus Kinase Inhibitor sales, revenue and market share for each player covered in this report.
The major players covered in Cancer Janus Kinase Inhibitor are:
Abbott Laboratories
Hanmi Pharmaceuticals
Celon Pharmaceuticals
Asana Biosciences
Gilead Sciences
Astra Zeneca
Kyowa Hakko
Eli Lilly
Dynamic Pharma
Incyte
Moleculin
Pfizer
Among other players domestic and global, Cancer Janus Kinase Inhibitor market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Janus Kinase Inhibitor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cancer Janus Kinase Inhibitor, with price, sales, revenue and global market share of Cancer Janus Kinase Inhibitor in 2018 and 2019.
Chapter 3, the Cancer Janus Kinase Inhibitor competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Janus Kinase Inhibitor breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Cancer Janus Kinase Inhibitor market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Cancer Janus Kinase Inhibitor sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Cancer Janus Kinase Inhibitor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cancer Janus Kinase Inhibitor Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Momelotinib
1.2.3 Lestaurtinib
1.2.4 Pacritinib
1.3 Market Analysis by Application
1.3.1 Overview: Global Cancer Janus Kinase Inhibitor Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Lung Cancer
1.3.3 Ovarian Cancer
1.3.4 Breast Cancer
1.3.5 Pancreatic Cancer
1.3.6 Hepatocellular Carcinoma
1.3.7 Colorectal cancer
1.3.8 Head & Neck Squamous Cell Carcinoma
1.3.9 Prostate Cancer
1.3.10 Glioblastoma
1.4 Overview of Global Cancer Janus Kinase Inhibitor Market
1.4.1 Global Cancer Janus Kinase Inhibitor Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hanmi Pharmaceuticals
2.2.1 Hanmi Pharmaceuticals Details
2.2.2 Hanmi Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Hanmi Pharmaceuticals SWOT Analysis
2.2.4 Hanmi Pharmaceuticals Product and Services
2.2.5 Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Celon Pharmaceuticals
2.3.1 Celon Pharmaceuticals Details
2.3.2 Celon Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Celon Pharmaceuticals SWOT Analysis
2.3.4 Celon Pharmaceuticals Product and Services
2.3.5 Celon Pharmaceuticals Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Asana Biosciences
2.4.1 Asana Biosciences Details
2.4.2 Asana Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Asana Biosciences SWOT Analysis
2.4.4 Asana Biosciences Product and Services
2.4.5 Asana Biosciences Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Gilead Sciences
2.5.1 Gilead Sciences Details
2.5.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Gilead Sciences SWOT Analysis
2.5.4 Gilead Sciences Product and Services
2.5.5 Gilead Sciences Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Astra Zeneca
2.6.1 Astra Zeneca Details
2.6.2 Astra Zeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Astra Zeneca SWOT Analysis
2.6.4 Astra Zeneca Product and Services
2.6.5 Astra Zeneca Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Kyowa Hakko
2.7.1 Kyowa Hakko Details
2.7.2 Kyowa Hakko Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Kyowa Hakko SWOT Analysis
2.7.4 Kyowa Hakko Product and Services
2.7.5 Kyowa Hakko Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly SWOT Analysis
2.8.4 Eli Lilly Product and Services
2.8.5 Eli Lilly Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Dynamic Pharma
2.9.1 Dynamic Pharma Details
2.9.2 Dynamic Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Dynamic Pharma SWOT Analysis
2.9.4 Dynamic Pharma Product and Services
2.9.5 Dynamic Pharma Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Incyte
2.10.1 Incyte Details
2.10.2 Incyte Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Incyte SWOT Analysis
2.10.4 Incyte Product and Services
2.10.5 Incyte Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Moleculin
2.11.1 Moleculin Details
2.11.2 Moleculin Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Moleculin SWOT Analysis
2.11.4 Moleculin Product and Services
2.11.5 Moleculin Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Pfizer SWOT Analysis
2.12.4 Pfizer Product and Services
2.12.5 Pfizer Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Cancer Janus Kinase Inhibitor Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Cancer Janus Kinase Inhibitor Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Cancer Janus Kinase Inhibitor Manufacturer Market Share in 2019
3.3.2 Top 6 Cancer Janus Kinase Inhibitor Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Cancer Janus Kinase Inhibitor Sales, Revenue and Market Share by Regions
4.1.1 Global Cancer Janus Kinase Inhibitor Sales and Market Share by Regions (2015-2020)
4.1.2 Global Cancer Janus Kinase Inhibitor Revenue and Market Share by Regions (2015-2020)
4.2 North America Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
4.3 Europe Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
4.5 South America Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Cancer Janus Kinase Inhibitor Sales, Revenue and Market Share by Country
5.1.1 North America Cancer Janus Kinase Inhibitor Sales and Market Share by Country (2015-2020)
5.1.2 North America Cancer Janus Kinase Inhibitor Revenue and Market Share by Country (2015-2020)
5.2 United States Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
5.3 Canada Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
5.4 Mexico Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Cancer Janus Kinase Inhibitor Sales, Revenue and Market Share by Country
6.1.1 Europe Cancer Janus Kinase Inhibitor Sales and Market Share by Country (2015-2020)
6.1.2 Europe Cancer Janus Kinase Inhibitor Revenue and Market Share by Country (2015-2020)
6.2 Germany Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
6.3 UK Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
6.4 France Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
6.5 Russia Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
6.6 Italy Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Cancer Janus Kinase Inhibitor Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Cancer Janus Kinase Inhibitor Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Cancer Janus Kinase Inhibitor Revenue and Market Share by Regions (2015-2020)
7.2 China Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
7.3 Japan Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
7.4 Korea Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
7.5 India Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
7.7 Australia Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Cancer Janus Kinase Inhibitor Sales, Revenue and Market Share by Country
8.1.1 South America Cancer Janus Kinase Inhibitor Sales and Market Share by Country (2015-2020)
8.1.2 South America Cancer Janus Kinase Inhibitor Revenue and Market Share by Country (2015-2020)
8.2 Brazil Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
8.3 Argentina Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Cancer Janus Kinase Inhibitor Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Cancer Janus Kinase Inhibitor Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Cancer Janus Kinase Inhibitor Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
9.3 Turkey Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
9.4 Egypt Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
9.5 South Africa Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Cancer Janus Kinase Inhibitor Sales and Market Share by Type (2015-2020)
10.2 Global Cancer Janus Kinase Inhibitor Revenue and Market Share by Type (2015-2020)
10.3 Global Cancer Janus Kinase Inhibitor Price by Type (2015-2020)
11 Global Cancer Janus Kinase Inhibitor Market Segment by Application
11.1 Global Cancer Janus Kinase Inhibitor Sales Market Share by Application (2015-2020)
11.2 Global Cancer Janus Kinase Inhibitor Revenue Market Share by Application (2015-2020)
11.3 Global Cancer Janus Kinase Inhibitor Price by Application (2015-2020)
12 Market Forecast
12.1 Global Cancer Janus Kinase Inhibitor Sales, Revenue and Growth Rate (2021-2025)
12.2 Cancer Janus Kinase Inhibitor Market Forecast by Regions (2021-2025)
12.2.1 North America Cancer Janus Kinase Inhibitor Market Forecast (2021-2025)
12.2.2 Europe Cancer Janus Kinase Inhibitor Market Forecast (2021-2025)
12.2.3 Asia-Pacific Cancer Janus Kinase Inhibitor Market Forecast (2021-2025)
12.2.4 South America Cancer Janus Kinase Inhibitor Market Forecast (2021-2025)
12.2.5 Middle East & Africa Cancer Janus Kinase Inhibitor Market Forecast (2021-2025)
12.3 Cancer Janus Kinase Inhibitor Market Forecast by Type (2021-2025)
12.3.1 Global Cancer Janus Kinase Inhibitor Sales Forecast by Type (2021-2025)
12.3.2 Global Cancer Janus Kinase Inhibitor Market Share Forecast by Type (2021-2025)
12.4 Cancer Janus Kinase Inhibitor Market Forecast by Application (2021-2025)
12.4.1 Global Cancer Janus Kinase Inhibitor Sales Forecast by Application (2021-2025)
12.4.2 Global Cancer Janus Kinase Inhibitor Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Cancer Janus Kinase Inhibitor Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cancer Janus Kinase Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cancer Janus Kinase Inhibitor Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Laboratories Cancer Janus Kinase Inhibitor Major Business
Table 9. Abbott Laboratories Cancer Janus Kinase Inhibitor Total Revenue (USD Million) (2018-2019)
Table 10. Abbott Laboratories SWOT Analysis
Table 11. Abbott Laboratories Cancer Janus Kinase Inhibitor Product and Services
Table 12. Abbott Laboratories Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Hanmi Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitor Major Business
Table 15. Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitor Total Revenue (USD Million) (2018-2019)
Table 16. Hanmi Pharmaceuticals SWOT Analysis
Table 17. Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitor Product and Services
Table 18. Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Celon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Celon Pharmaceuticals Cancer Janus Kinase Inhibitor Major Business
Table 21. Celon Pharmaceuticals Cancer Janus Kinase Inhibitor Total Revenue (USD Million) (2018-2019)
Table 22. Celon Pharmaceuticals SWOT Analysis
Table 23. Celon Pharmaceuticals Cancer Janus Kinase Inhibitor Product and Services
Table 24. Celon Pharmaceuticals Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Asana Biosciences Basic Information, Manufacturing Base and Competitors
Table 26. Asana Biosciences Cancer Janus Kinase Inhibitor Major Business
Table 27. Asana Biosciences Cancer Janus Kinase Inhibitor Total Revenue (USD Million) (2018-2019)
Table 28. Asana Biosciences SWOT Analysis
Table 29. Asana Biosciences Cancer Janus Kinase Inhibitor Product and Services
Table 30. Asana Biosciences Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 32. Gilead Sciences Cancer Janus Kinase Inhibitor Major Business
Table 33. Gilead Sciences Cancer Janus Kinase Inhibitor Total Revenue (USD Million) (2018-2019)
Table 34. Gilead Sciences SWOT Analysis
Table 35. Gilead Sciences Cancer Janus Kinase Inhibitor Product and Services
Table 36. Gilead Sciences Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Astra Zeneca Basic Information, Manufacturing Base and Competitors
Table 38. Astra Zeneca Cancer Janus Kinase Inhibitor Major Business
Table 39. Astra Zeneca Cancer Janus Kinase Inhibitor Total Revenue (USD Million) (2018-2019)
Table 40. Astra Zeneca SWOT Analysis
Table 41. Astra Zeneca Cancer Janus Kinase Inhibitor Product and Services
Table 42. Astra Zeneca Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Kyowa Hakko Basic Information, Manufacturing Base and Competitors
Table 44. Kyowa Hakko Cancer Janus Kinase Inhibitor Major Business
Table 45. Kyowa Hakko Cancer Janus Kinase Inhibitor Total Revenue (USD Million) (2018-2019)
Table 46. Kyowa Hakko SWOT Analysis
Table 47. Kyowa Hakko Cancer Janus Kinase Inhibitor Product and Services
Table 48. Kyowa Hakko Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 50. Eli Lilly Cancer Janus Kinase Inhibitor Major Business
Table 51. Eli Lilly Cancer Janus Kinase Inhibitor Total Revenue (USD Million) (2018-2019)
Table 52. Eli Lilly SWOT Analysis
Table 53. Eli Lilly Cancer Janus Kinase Inhibitor Product and Services
Table 54. Eli Lilly Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Dynamic Pharma Basic Information, Manufacturing Base and Competitors
Table 56. Dynamic Pharma Cancer Janus Kinase Inhibitor Major Business
Table 57. Dynamic Pharma Cancer Janus Kinase Inhibitor Total Revenue (USD Million) (2018-2019)
Table 58. Dynamic Pharma SWOT Analysis
Table 59. Dynamic Pharma Cancer Janus Kinase Inhibitor Product and Services
Table 60. Dynamic Pharma Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Incyte Basic Information, Manufacturing Base and Competitors
Table 62. Incyte Cancer Janus Kinase Inhibitor Major Business
Table 63. Incyte Cancer Janus Kinase Inhibitor Total Revenue (USD Million) (2018-2019)
Table 64. Incyte SWOT Analysis
Table 65. Incyte Cancer Janus Kinase Inhibitor Product and Services
Table 66. Incyte Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Moleculin Basic Information, Manufacturing Base and Competitors
Table 68. Moleculin Cancer Janus Kinase Inhibitor Major Business
Table 69. Moleculin Cancer Janus Kinase Inhibitor Total Revenue (USD Million) (2018-2019)
Table 70. Moleculin SWOT Analysis
Table 71. Moleculin Cancer Janus Kinase Inhibitor Product and Services
Table 72. Moleculin Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Cancer Janus Kinase Inhibitor Major Business
Table 75. Pfizer Cancer Janus Kinase Inhibitor Total Revenue (USD Million) (2018-2019)
Table 76. Pfizer SWOT Analysis
Table 77. Pfizer Cancer Janus Kinase Inhibitor Product and Services
Table 78. Pfizer Cancer Janus Kinase Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Cancer Janus Kinase Inhibitor Sales by Manufacturer (2018-2019) (K MT)
Table 80. Global Cancer Janus Kinase Inhibitor Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Cancer Janus Kinase Inhibitor Sales by Regions (2015-2020) (K MT)
Table 82. Global Cancer Janus Kinase Inhibitor Sales Market Share by Regions (2015-2020)
Table 83. Global Cancer Janus Kinase Inhibitor Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Cancer Janus Kinase Inhibitor Sales by Countries (2015-2020) (K MT)
Table 85. North America Cancer Janus Kinase Inhibitor Sales Market Share by Countries (2015-2020)
Table 86. North America Cancer Janus Kinase Inhibitor Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Cancer Janus Kinase Inhibitor Revenue Market Share by Countries (2015-2020)
Table 88. Europe Cancer Janus Kinase Inhibitor Sales by Countries (2015-2020) (K MT)
Table 89. Europe Cancer Janus Kinase Inhibitor Sales Market Share by Countries (2015-2020)
Table 90. Europe Cancer Janus Kinase Inhibitor Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Cancer Janus Kinase Inhibitor Sales by Regions (2015-2020) (K MT)
Table 92. Asia-Pacific Cancer Janus Kinase Inhibitor Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Cancer Janus Kinase Inhibitor Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Cancer Janus Kinase Inhibitor Sales by Countries (2015-2020) (K MT)
Table 95. South America Cancer Janus Kinase Inhibitor Sales Market Share by Countries (2015-2020)
Table 96. South America Cancer Janus Kinase Inhibitor Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Cancer Janus Kinase Inhibitor Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Cancer Janus Kinase Inhibitor Sales by Countries (2015-2020) (K MT)
Table 99. Middle East & Africa Cancer Janus Kinase Inhibitor Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Cancer Janus Kinase Inhibitor Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Cancer Janus Kinase Inhibitor Revenue Market Share by Countries (2015-2020)
Table 102. Global Cancer Janus Kinase Inhibitor Sales by Type (2015-2020) (K MT)
Table 103. Global Cancer Janus Kinase Inhibitor Sales Share by Type (2015-2020)
Table 104. Global Cancer Janus Kinase Inhibitor Revenue by Type (2015-2020) (USD Million)
Table 105. Global Cancer Janus Kinase Inhibitor Revenue Share by Type (2015-2020)
Table 106. Global Cancer Janus Kinase Inhibitor Sales by Application (2015-2020) (K MT)
Table 107. Global Cancer Janus Kinase Inhibitor Sales Share by Application (2015-2020)
Table 108. Global Cancer Janus Kinase Inhibitor Sales Forecast by Regions (2021-2025) (K MT)
Table 109. Global Cancer Janus Kinase Inhibitor Market Share Forecast by Regions (2021-2025)
Table 110. Global Cancer Janus Kinase Inhibitor Sales Forecast by Type (2021-2025) (K MT)
Table 111. Global Cancer Janus Kinase Inhibitor Market Share Forecast by Type (2021-2025)
Table 112. Global Cancer Janus Kinase Inhibitor Sales Forecast by Application (2021-2025)
Table 113. Global Cancer Janus Kinase Inhibitor Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Cancer Janus Kinase Inhibitor Picture
Figure 2. Global Sales Market Share of Cancer Janus Kinase Inhibitor by Type in 2019
Figure 3. Momelotinib Picture
Figure 4. Lestaurtinib Picture
Figure 5. Pacritinib Picture
Figure 6. Cancer Janus Kinase Inhibitor Sales Market Share by Application in 2018
Figure 7. Lung Cancer Picture
Figure 8. Ovarian Cancer Picture
Figure 9. Breast Cancer Picture
Figure 10. Pancreatic Cancer Picture
Figure 11. Hepatocellular Carcinoma Picture
Figure 12. Colorectal cancer Picture
Figure 13. Head & Neck Squamous Cell Carcinoma Picture
Figure 14. Prostate Cancer Picture
Figure 15. Glioblastoma Picture
Figure 16. Global Cancer Janus Kinase Inhibitor Market Status and Outlook (2015-2025) (USD Million)
Figure 17. United States Cancer Janus Kinase Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Canada Cancer Janus Kinase Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Mexico Cancer Janus Kinase Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Germany Cancer Janus Kinase Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 21. France Cancer Janus Kinase Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 22. UK Cancer Janus Kinase Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Russia Cancer Janus Kinase Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Italy Cancer Janus Kinase Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 25. China Cancer Janus Kinase Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Japan Cancer Janus Kinase Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Korea Cancer Janus Kinase Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 28. India Cancer Janus Kinase Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Southeast Asia Cancer Janus Kinase Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Australia Cancer Janus Kinase Inhibitor Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 31. Brazil Cancer Janus Kinase Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Egypt Cancer Janus Kinase Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Saudi Arabia Cancer Janus Kinase Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 34. South Africa Cancer Janus Kinase Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Turkey Cancer Janus Kinase Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Global Cancer Janus Kinase Inhibitor Sales Market Share by Manufacturer in 2019
Figure 37. Global Cancer Janus Kinase Inhibitor Revenue Market Share by Manufacturer in 2019
Figure 38. Top 3 Cancer Janus Kinase Inhibitor Manufacturer (Revenue) Market Share in 2019
Figure 39. Top 6 Cancer Janus Kinase Inhibitor Manufacturer (Revenue) Market Share in 2019
Figure 40. Key Manufacturer Market Share Trend
Figure 41. Global Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 42. Global Cancer Janus Kinase Inhibitor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. Global Cancer Janus Kinase Inhibitor Revenue Market Share by Regions (2015-2020)
Figure 44. Global Cancer Janus Kinase Inhibitor Revenue Market Share by Regions in 2018
Figure 45. North America Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
Figure 46. Europe Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
Figure 48. South America Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
Figure 49. Middle East & Africa Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020)
Figure 50. North America Cancer Janus Kinase Inhibitor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. North America Cancer Janus Kinase Inhibitor Sales Market Share by Countries (2015-2020)
Figure 52. North America Cancer Janus Kinase Inhibitor Sales Market Share by Countries in 2018
Figure 53. North America Cancer Janus Kinase Inhibitor Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 54. North America Cancer Janus Kinase Inhibitor Revenue Market Share by Countries in 2018
Figure 55. United States Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 56. Canada Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 57. Mexico Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Europe Cancer Janus Kinase Inhibitor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Europe Cancer Janus Kinase Inhibitor Revenue Market Share by Countries (2015-2020)
Figure 60. Europe Cancer Janus Kinase Inhibitor Revenue Market Share by Countries in 2019
Figure 61. Germany Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 62. UK Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 63. France Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 64. Russia Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Italy Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Asia-Pacific Cancer Janus Kinase Inhibitor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. Asia-Pacific Cancer Janus Kinase Inhibitor Sales Market Share by Regions 2019
Figure 68. Asia-Pacific Cancer Janus Kinase Inhibitor Revenue Market Share by Regions 2019
Figure 69. China Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 70. Japan Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 71. Korea Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 72. India Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Southeast Asia Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 74. South America Cancer Janus Kinase Inhibitor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. South America Cancer Janus Kinase Inhibitor Sales Market Share by Countries in 2019
Figure 76. South America Cancer Janus Kinase Inhibitor Revenue Market Share by Countries in 2019
Figure 77. Brazil Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 78. Argentina Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Middle East and Africa Cancer Janus Kinase Inhibitor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 80. Middle East and Africa Cancer Janus Kinase Inhibitor Sales Market Share by Countries in 2019
Figure 81. Middle East and Africa Cancer Janus Kinase Inhibitor Revenue Market Share by Countries (2015-2020)
Figure 82. Middle East and Africa Cancer Janus Kinase Inhibitor Revenue Market Share by Countries in 2019
Figure 83. Saudi Arabia Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 84. Egypt Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 85. Turkey Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 86. South Africa Cancer Janus Kinase Inhibitor Sales and Growth Rate (2015-2020) (K MT)
Figure 87. Global Cancer Janus Kinase Inhibitor Sales and Growth Rate (2021-2025) (K MT)
Figure 88. Global Cancer Janus Kinase Inhibitor Revenue and Growth Rate (2021-2025) (USD Million)
Figure 89. North America Sales Cancer Janus Kinase Inhibitor Market Forecast (2021-2025) (K MT)
Figure 90. Europe Sales Cancer Janus Kinase Inhibitor Market Forecast (2021-2025) (K MT)
Figure 91. Asia-Pacific Sales Cancer Janus Kinase Inhibitor Market Forecast (2021-2025) (K MT)
Figure 92. South America Sales Cancer Janus Kinase Inhibitor Market Forecast (2021-2025) (K MT)
Figure 93. Middle East & Africa Sales Cancer Janus Kinase Inhibitor Market Forecast (2021-2025) (K MT)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel
乳がん検診の世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Breast Cancer Screening market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.0% in the forecast period of 2020 to 2025 and will expected to reach USD 2352.1 million by 2025, from USD 1726.4 million in 2019. The Brea…- がん免疫調節剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cancer Immunomodulator market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cancer Immunomodulator…
- がん画像システムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cancer Imaging System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cancer Imaging System m…
- 乳がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Breast Cancer Therapeutics Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Breast Cance…
- 子宮頸がん治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cervical Cancer Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.2% in the forecast period of 2020 to 2025 and will expected to reach USD 14770 million by 2025, from USD 13550 million in 2019. The Cervical Cancer …